<?xml version="1.0" encoding="UTF-8" ?>
	<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	  <channel>
	  <copyright>Copyright 2009 Medical News Today</copyright>
	  <description>Latest Fibromyalgia News From Medical News Today.</description>
	  <link>http://www.medicalnewstoday.com/sections/fibromyalgia/</link>
	  <title>Fibromyalgia News From Medical News Today</title>
	  <webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster>
	  <managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor>
	  <language>en-us</language><atom:link href="http://www.medicalnewstoday.com/rss/fibromyalgia.xml" rel="self" type="application/rss+xml" /><item><title>PatientsLikeMe Adds Online Community For People With Chronic Fatigue Syndrome</title><pubDate>Sun, 01 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169367.php</link><guid>http://www.medicalnewstoday.com/articles/169367.php</guid><description> PatientsLikeMe, the leading online community for people with life&#45;changing conditions, announces the expansion of its fibromyalgia community to welcome patients with chronic fatigue syndrome (CFS), also know as myalgic encephalomyelitis (ME). By sharing information about their experience with CFS, patients can now find others just like them, including other patients who may have the newly discovered xenotropic murine leukemia virus&#45;related virus (XMRV).</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Cooperative Diagnostics Launches New Diagnostic Test For Chronic Fatigue Syndrome Associated Virus</title><pubDate>Tue, 27 Oct 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168835.php</link><guid>http://www.medicalnewstoday.com/articles/168835.php</guid><description>Cooperative Diagnostics, LLC announced today the availability of a new diagnostic assay for Xenotropic Murine Leukemia&#45;Related Virus (XMRV) to assist physicians in the diagnosis of Chronic Fatigue Syndrome and other disorders potentially caused by the virus. Testing services will also be made available to the general public.   The Simplex XMRV test identifies patients infected with XMRV.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Early Treatment Of Fibromyalgia More Effective</title><pubDate>Fri, 23 Oct 2009 03:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/168434.php</link><guid>http://www.medicalnewstoday.com/articles/168434.php</guid><description>People suffering from fibromyalgia have reduced activity in the parts of the brain that inhibit the experience of pain. Drugs that affect the CNS can be effective against the disease, and are thought to be even more so if administered early in its course. This according to a new thesis from the Swedish medical university Karolinska Institutet.    "It's a common misconception that fibromyalgia is a manifestation of mental problems," says Karin B.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Forest Laboratories And Cypress Bioscience Announce Study Shows Patients Treated With Savella Experience Improvements In Pain And Physical Function</title><pubDate>Tue, 20 Oct 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/167879.php</link><guid>http://www.medicalnewstoday.com/articles/167879.php</guid><description>Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Fibromyalgia: Debilitating But Treatable With Chiropractic Care</title><pubDate>Sun, 09 Aug 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/160161.php</link><guid>http://www.medicalnewstoday.com/articles/160161.php</guid><description>Foundation for Chiropractic Progress (www.f4cp.com), a not&#45;for&#45;profit organization dedicated to increasing public awareness of the benefits of chiropractic, announced today that chiropractic care has been shown to reduce the agonizing pain, debilitating fatigue, and joint stiffness associated with fibromyalgia.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Jazz Pharmaceuticals And UCB Announce Second Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia Meets Primary Endpoints</title><pubDate>Thu, 25 Jun 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/155288.php</link><guid>http://www.medicalnewstoday.com/articles/155288.php</guid><description>Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB) announced today positive preliminary top&#45;line results from the second of two Phase III clinical trials of sodium oxybate (JZP&#45;6) for the treatment of fibromyalgia.  Confirming the positive results from the first Phase III study, this international, placebo&#45;controlled trial of sodium oxybate to treat fibromyalgia achieved its key endpoints.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Fibromyalgia: Doctor Offers Unbiased Overview In New Book</title><pubDate>Wed, 10 Jun 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/153177.php</link><guid>http://www.medicalnewstoday.com/articles/153177.php</guid><description>As many as fifteen million American women suffer from a disabling medical condition known as fibromyalgia. In the medical community, sides have been drawn over whether fibromyalgia is a genuine syndrome or a catchall diagnosis based on vague clinical criteria. In The Fibromyalgia Controversy, M. Clement Hall, MD presents an unbiased overview of the fibromyalgia situation today and reviews the most up&#45;to&#45;date opinions and studies on this condition and its surrounding controversy.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Experts Launch Think Tank For Mystery Disease</title><pubDate>Tue, 09 Jun 2009 05:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/153019.php</link><guid>http://www.medicalnewstoday.com/articles/153019.php</guid><description>Ten leading scientists in Europe have formed a Think Tank for ME and will hold their first meeting on the 13th of June. They want to initiate an effective research effort to find the secret behind the mystery disease that cripples an increasing number of lives. Myalgic Encephalomyelitis, often referred to as Chronic Fatigue Syndrome (CFS), is a disease which affects at least one million individuals in the US, and an even greater number in Europe.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>What Is Lyrica (pregabalin)? What Does Lyrica Treat?</title><pubDate>Fri, 22 May 2009 05:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/151139.php</link><guid>http://www.medicalnewstoday.com/articles/151139.php</guid><description>Lyrica is Pfizer's trade name for a drug called pregabalin. Pregabalin is an anticonvulsant (anti&#45;seizure) drug that is often used to treat neuropathic pain as well as partial seizures that are common in temporal lobe epilepsy. In Europe, pregabalin is also approved to treat generalized anxiety disorder.    What does Lyrica treat?     Lyrica or pregabalin has been approved in the U.S.</description><category domain="http://www.medicalnewstoday.com/sections/pharma_industry/">Pharma Industry / Biotech Industry</category></item><item><title>What Is Fibromyalgia? What Causes Fibromyalgia?</title><pubDate>Wed, 22 Apr 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/147083.php</link><guid>http://www.medicalnewstoday.com/articles/147083.php</guid><description>The word fibromyalgia comes from the Greek myos meaning "muscle", Greek algos meaning "pain", and New Latin fibro meaning "fibrous tissue". According to MediLexicon's medical dictionary, fibromyalgia is "A common syndrome of chronic widespread soft&#45;tissue pain accompanied by weakness, fatigue, and sleep disturbances; the cause is unknown." Fibromyalgia is a common and chronic disorder.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Pilot Study Finds Inexpensive Drug Appears To Relieve Fibromyalgia Pain</title><pubDate>Mon, 20 Apr 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/146634.php</link><guid>http://www.medicalnewstoday.com/articles/146634.php</guid><description>For Tara Campbell, the onset of her fibromyalgia began slowly with repeated sore throats, fevers and fatigue. By the time she was diagnosed, a year later, she had become so debilitated by flulike symptoms and exhaustion that she often couldn't get off the couch all day.    "Fall, a year ago, I hit my very, very worst," said Campbell, 39, of Walnut Creek, Calif. "I felt overall pain to the point that even when my children or husband just touched me it hurt.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Pfizer Discontinues Development Of Two Phase 3 Compounds</title><pubDate>Thu, 26 Feb 2009 06:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/140429.php</link><guid>http://www.medicalnewstoday.com/articles/140429.php</guid><description>Pfizer Inc announced today that, following a review of the development and commercial portfolios in the Primary Care Business Unit, it is terminating Phase 3 development programs for the investigational compounds esreboxetine for fibromyalgia and PD 332,334 for generalized anxiety disorder (GAD).</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Is It Just Pain...or Is It Fibromyalgia?</title><pubDate>Wed, 18 Feb 2009 07:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/139484.php</link><guid>http://www.medicalnewstoday.com/articles/139484.php</guid><description>Months of constant pain, restless sleep and being drained of energy will make anyone seek help. Yet after the doctor has prescribed three different treatment regimens, the pain remains, the sleep is still restless and the body still lacks the proper energy to function. The patient becomes discouraged, as each attempt at healing the problem proves fruitless.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>FDA Approves Fibromyalgia Drug &#45; Savella(TM) (milnacipran HCl), A Selective Serotonin And Norepinephrine Dual Reuptake Inhibitor</title><pubDate>Fri, 16 Jan 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/135635.php</link><guid>http://www.medicalnewstoday.com/articles/135635.php</guid><description>Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella(TM) (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function, afflicting as many as six million people in the United States.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Fibromyalgia Study Hopes To Decrease Pain, Other Symptoms</title><pubDate>Thu, 15 Jan 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/135528.php</link><guid>http://www.medicalnewstoday.com/articles/135528.php</guid><description> Researchers at the Indiana University School of Medicine seek 200 people with fibromyalgia to determine if motivational reminder telephone calls can prompt patients to exercise more regularly.               Fibromyalgia is a disease that causes pain in the muscles and tissue surrounding joints in nearly 5 percent of the population.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Forest Laboratories, Inc. And Cypress Bioscience, Inc. Announce Positive Results Of Phase III Study Of Milnacipran For The Management Of Fibromyalgia</title><pubDate>Tue, 09 Dec 2008 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/132196.php</link><guid>http://www.medicalnewstoday.com/articles/132196.php</guid><description>Forest Laboratories, Inc. (NYSE:  FRX) and Cypress Bioscience, Inc. (Nasdaq:  CYPB)  announced positive top&#45;line results from a 1,025 patient, multicenter, double&#45;blind, placebo&#45;controlled phase III study of milnacipran for the management of fibromyalgia.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Phase 3 Study Of Subcutaneous Relistor For Opioid&#45;Induced Constipation For Chronic Non&#45;Cancer Pain</title><pubDate>Fri, 28 Nov 2008 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/131139.php</link><guid>http://www.medicalnewstoday.com/articles/131139.php</guid><description>Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR&#174; (methylnaltrexone bromide) subcutaneous injection to treat opioid&#45;induced constipation (OIC) in patients with chronic, non&#45;cancer pain achieved statistical significance for the primary and key secondary efficacy endpoints.</description><category domain="http://www.medicalnewstoday.com/sections/palliative_care/">Palliative Care / Hospice Care</category></item><item><title>Jazz Pharmaceuticals And UCB Announce Positive Phase III Results For Sodium Oxybate In Fibromyalgia</title><pubDate>Fri, 21 Nov 2008 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/130276.php</link><guid>http://www.medicalnewstoday.com/articles/130276.php</guid><description>Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB) announced today positive preliminary top&#45;line results from the first of two Phase III clinical trials of sodium oxybate (JZP&#45;6) for the treatment of fibromyalgia. The randomized, double&#45;blind, placebo&#45;controlled study achieved its key endpoints, demonstrating that sodium oxybate significantly decreased pain and fatigue, and improved daily function in patients with fibromyalgia.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Fibromyalgia Can No Longer Be Called The "Invisible" Syndrome</title><pubDate>Tue, 04 Nov 2008 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/127979.php</link><guid>http://www.medicalnewstoday.com/articles/127979.php</guid><description>Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.   "Fibromyalgia is frequently considered an 'invisible syndrome' since musculoskeletal imaging is negative," said Eric Guedj, M.D.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Fight Off Aches &#38; Pains This Winter With Extra Vitamin D</title><pubDate>Sat, 01 Nov 2008 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/127762.php</link><guid>http://www.medicalnewstoday.com/articles/127762.php</guid><description>It's no wonder many people feel achy and sore, and sometimes tired and depressed, during winter months they're often not getting enough vitamin D. The body makes vitamin D from the sun's ultraviolet rays, so it's known as the sunshine vitamin, but this source is in short supply throughout late fall and winter.    According to an extensive review of clinical research in a report from Pain Treatment Topics (</description><category domain="http://www.medicalnewstoday.com/sections/nutrition-agriculture/">Nutrition / Diet</category></item><item><title>Coping With Aches And Pains, From The Mayo Clinic</title><pubDate>Thu, 30 Oct 2008 10:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/127559.php</link><guid>http://www.medicalnewstoday.com/articles/127559.php</guid><description>Contrary to popular belief, aches and pains are not a typical part of aging. Age alone does not mean a person automatically experiences aches and pains. Pain can be a red flag that points to a disease, illness or injury. Any pain that interferes with the activities of daily life is worthy of attention.   MayoClinic.com highlights a number of conditions that can cause major aches and pains as a person ages, and offers information on diagnosis, treatment, self&#45;care and coping.</description><category domain="http://www.medicalnewstoday.com/sections/pain/">Pain / Anesthetics</category></item><item><title>Johns Hopkins And National Fibromyalgia Association Launch Fibromyalgia Educational Initiative To Bridge Chasm In Diagnosis And Care</title><pubDate>Mon, 27 Oct 2008 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/126915.php</link><guid>http://www.medicalnewstoday.com/articles/126915.php</guid><description>The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the National Fibromyalgia Association announced today the launch of the Fibromyalgia Circle of Care Initiative at the ACR/ARHP Annual Scientific Meeting, October 24&#45;29, 2008 in San Francisco. The outcomes&#45;based educational initiative will educate providers about the disease state and the latest therapeutic options; thus, driving accurate and early diagnosis of fibromyalgia for the ten million U.S.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Three In Five Patients Feel Depressed Or Anxious As A Result Of Their Pain</title><pubDate>Wed, 22 Oct 2008 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/126305.php</link><guid>http://www.medicalnewstoday.com/articles/126305.php</guid><description>Despite treatment efforts, chronic pain management is failing     one in three (n = 377) patients suffering from severe chronic pain, and three     in five (n = 336) patients feel moderately or extremely anxious or depressed     as a result of their pain. Whilst eight in ten (n = 377) chronic pain     patients are taking prescription medication, one in two (n = 307) of these     patients are suffering the additional burden of side effects.</description><category domain="http://www.medicalnewstoday.com/sections/pain/">Pain / Anesthetics</category></item><item><title>FDA Defers Final Action On Milnacipran New Drug Application</title><pubDate>Tue, 21 Oct 2008 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/126064.php</link><guid>http://www.medicalnewstoday.com/articles/126064.php</guid><description>Forest   Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB)   (the "Companies") announced that the U.S.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item><item><title>Primary Care Doctors Play Key Role In Fibromyalgia Diagnosis And Management</title><pubDate>Wed, 01 Oct 2008 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/123639.php</link><guid>http://www.medicalnewstoday.com/articles/123639.php</guid><description>Primary care physicians are at the forefront of fibromyalgia management, and deservedly so, a pain management expert said at a Meet&#45;the&#45;Experts Program entitled "Case Studies in Fibromyalgia: Connecting the Dots from Diagnosis to Pain Management" held in conjunction with PAINWeek 2008.      "That's just as it should be," moderator Kevin L. Zacharoff, MD, an anesthesiologist and pain management consultant in Setauket, New York, noted.</description><category domain="http://www.medicalnewstoday.com/sections/fibromyalgia/">Fibromyalgia</category></item></channel></rss>